POLIDENT DENTURE CLEANSER TABLETS

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04 report with the FDA on 2013-07-30 for POLIDENT DENTURE CLEANSER TABLETS manufactured by Glaxosmithkline.

Event Text Entries

[17150698] This case was reported by a consumer and described the occurrence of urinary tract infection in a (b)(6) female patient who received two variants or double salt denture cleanser (polident denture cleanser tablets and polident overnight denture cleanser tablets) for dentures. A physician or other health care professional has not verified this report. The patient's past medical history included urinary tract infection. Concurrent medical conditions included bipolar, hypothyroidism, knee arthritis and lupus. Concurrent medications included tylenol with codeine no. 3 (tylenol with codeine #3), "azo", hydrochlorothiazide, clonazepam, semisodium valproate (depakote, thyroxine sodium (levothyroxine), injectable arthritis medication and unknown injection for lupus. On an unknown date(s), the patient started the formulations of double salt denture cleanser. At an unknown time after starting the formulations for double salt denture cleanser, the patient experienced urinary tract infection and burning on urination. The patient was hospitalized. The patient was treated with ciprofloxacin hydrochloride (cipro). Treatment with double salt denture cleanser was continued. At the time of reporting, the events were unresolved. Sae reported (b)(6) via phone: consumer reported that she has frequent visits to the hospital for urinary tract infections. She stated that approximately two years ago after she had her teeth extracted she was admitted into the hospital for a urinary tract infection for three days. She could not provide the specific dates or details about her hospital admission. She reported that she did not tell the doctor's that she was using polident while she was in the hospital. She also stated that her doctor now is not aware that she's using polident. She stated that the cause of her frequent urinary tract infections is unknown. She stated that she has seen a kidney specialist and was told that her kidneys look good. Consumer reported that when she has a urinary tract infection she wakes up at night and has really bad burning while urinating. She stated that she was started on cipro 500 mg twice a day yesterday, (b)(6) 2013, to treat her current urinary infection. She reported that she has appointment with her doctor on the (b)(6) for a follow up but did not state the month of her follow up appointment.
Patient Sequence No: 1, Text Type: D, B5


[17366907] Polident tablets are manufactured in (b)(4). The lot number for this product is available; however, it is unknown whether the product will be returned for quality assurance testing. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1020379-2013-00007
MDR Report Key3259938
Report Source04
Date Received2013-07-30
Date of Report2013-07-29
Date Mfgr Received2013-07-25
Date Added to Maude2013-08-15
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer StreetPO BOX 13398
Manufacturer CityRESEARCH TRIANGLE PARK NC 27709
Manufacturer CountryUS
Manufacturer Postal27709
Manufacturer Phone8888255249
Manufacturer G1BLOCK DRUG CO., INC., MEMPHIS FACILITY
Manufacturer Street2149 HARBOR AVE.
Manufacturer CityMEMPHIS TN 38113
Manufacturer CountryUS
Manufacturer Postal Code38113
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePOLIDENT DENTURE CLEANSER TABLETS
Generic NameDOUBLE SALT DENTURE CLEANSER
Product CodeJER
Date Received2013-07-30
Model NumberNA
Catalog NumberNA
Lot NumberMB1913
ID NumberNA
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerGLAXOSMITHKLINE
Manufacturer AddressRESEARCH TRIANGLE PARK NC 27709 US 27709


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2013-07-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.